| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-09-24 |
4 |
OE |
$2.38 |
$69,272 |
D/D |
29,167 |
246,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-10-22 |
4 |
OE |
$2.38 |
$69,272 |
D/D |
29,167 |
266,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-05 |
4 |
OE |
$2.38 |
$1,299 |
D/D |
547 |
249,859 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-08 |
4 |
OE |
$2.38 |
$31,951 |
D/D |
13,453 |
263,113 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-22 |
4 |
OE |
$2.38 |
$103,906 |
D/D |
43,750 |
299,062 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-12-17 |
4 |
OE |
$2.38 |
$24,740 |
D/D |
10,417 |
284,479 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-12-29 |
4 |
OE |
$2.38 |
$45,914 |
D/D |
19,332 |
298,811 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-10-26 |
4 |
OE |
$2.69 |
$534,197 |
D/D |
99,536 |
1,840,087 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-09 |
4 |
OE |
$2.69 |
$382,210 |
D/D |
108,000 |
1,989,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-28 |
4 |
OE |
$4.03 |
$766,305 |
D/D |
125,384 |
1,681,834 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-01 |
4 |
OE |
$4.03 |
$72,822 |
D/D |
18,070 |
1,699,904 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-31 |
4 |
OE |
$4.03 |
$21,419 |
D/D |
5,315 |
1,687,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-11-28 |
4 |
OE |
$4.03 |
$54,465 |
D/D |
13,515 |
1,692,682 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-27 |
4 |
OE |
$4.42 |
$323,040 |
D/D |
62,000 |
1,943,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-02-26 |
4 |
OE |
$4.75 |
$95,000 |
D/D |
20,000 |
841,322 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-17 |
4 |
OE |
$4.75 |
$190,000 |
D/D |
40,000 |
848,094 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-04-17 |
4 |
OE |
$4.75 |
$95,000 |
D/D |
20,000 |
851,543 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-18 |
4 |
OE |
$5.10 |
$818,570 |
D/D |
145,664 |
1,171,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-19 |
4 |
OE |
$5.18 |
$181,300 |
D/D |
35,000 |
1,066,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-08 |
4 |
OE |
$5.18 |
$34,776 |
D/D |
6,411 |
1,038,368 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-09 |
4 |
OE |
$6.90 |
$7,169 |
D/D |
1,039 |
1,032,996 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-10 |
4 |
OE |
$6.90 |
$80,765 |
D/D |
11,705 |
1,043,662 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-13 |
4 |
OE |
$6.90 |
$109,331 |
D/D |
15,845 |
1,059,507 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-17 |
4 |
OE |
$6.90 |
$225,554 |
D/D |
32,689 |
1,076,351 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-21 |
4 |
OE |
$6.90 |
$908,065 |
D/D |
110,930 |
1,088,656 |
0 |
- |
|
283 Records found
|
|
Page 2 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
